These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35210813)

  • 1. Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis.
    Tang D; Zhang D; Heng Y; Zhu XK; Lin HQ; Zhou J; Tao L; Lu LM
    J Inflamm Res; 2022; 15():1079-1097. PubMed ID: 35210813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.
    Franz L; Alessandrini L; Fasanaro E; Gaudioso P; Carli A; Nicolai P; Marioni G
    Ann Diagn Pathol; 2021 Feb; 50():151657. PubMed ID: 33189034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance.
    Zhang D; Zhou J; Tang D; Zhou L; Chou L; Chou KY; Tao L; Lu LM
    Clin Immunol; 2017 Feb; 175():34-40. PubMed ID: 27876461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
    Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J
    Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer.
    Kwantwi LB; Wang S; Zhang W; Peng W; Cai Z; Sheng Y; Xiao H; Wang X; Wu Q
    Bioengineered; 2021 Dec; 12(1):6996-7006. PubMed ID: 34519637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Wang TT; Zhao YL; Peng LS; Chen N; Chen W; Lv YP; Mao FY; Zhang JY; Cheng P; Teng YS; Fu XL; Yu PW; Guo G; Luo P; Zhuang Y; Zou QM
    Gut; 2017 Nov; 66(11):1900-1911. PubMed ID: 28274999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8
    Ji Y; Heng Y; Zhu X; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
    Transl Oncol; 2024 Jul; 45():101936. PubMed ID: 38678970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of immune cell genetic variants associated with tumor microenvironment response in laryngeal squamous cell carcinoma (LSCC) in terms of clinicopathological features.
    Horozoglu C; Sonmez D; Demirkol S; Hakan MT; Kaleler I; Hepokur C; Verim A; Yaylim I
    Pathol Res Pract; 2021 Dec; 228():153665. PubMed ID: 34717150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma.
    Yang Z; Wang J; Chen C; Sun P; Yu Y
    Technol Cancer Res Treat; 2021; 20():15330338211046432. PubMed ID: 34632870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis.
    Sun R; Xiong Y; Liu H; Gao C; Su L; Weng J; Yuan X; Zhang D; Feng J
    Transl Oncol; 2020 Oct; 13(10):100825. PubMed ID: 32698059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity.
    Tian H; Shi G; Wang Q; Li Y; Yang Q; Li C; Yang G; Wu M; Xie Q; Zhang S; Yang Y; Xiang R; Yu D; Wei Y; Deng H
    Signal Transduct Target Ther; 2016; 1():16025. PubMed ID: 29263903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor associated neutrophils governs tumor progression through an IL-10/STAT3/PD-L1 feedback signaling loop in lung cancer.
    Zhang S; Sun L; Zuo J; Feng D
    Transl Oncol; 2024 Feb; 40():101866. PubMed ID: 38128466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma.
    Souza VG; Santos DJS; Silva AG; Ribeiro RIMA; Loyola AM; Cardoso SV; Miranda CSS; Cardoso LPV
    J Appl Oral Sci; 2022; 30():e20210344. PubMed ID: 35195152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade.
    Tachinami H; Nishii N; Xia Y; Kashima Y; Ohno T; Nagai S; Li L; Lau W; Tomihara K; Noguchi M; Azuma M
    Oral Oncol; 2019 Apr; 91():21-28. PubMed ID: 30926058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous cell carcinoma cell-derived GM-CSF regulates PD-L1 expression in tumor-associated macrophages through the JAK2/STAT3 signaling pathway.
    Wang P; Tao L; Yu Y; Wang Q; Ye P; Sun Y; Zhou J
    Am J Cancer Res; 2023; 13(2):589-601. PubMed ID: 36895967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer.
    Shi X; Zhang X; Li J; Zhao H; Mo L; Shi X; Hu Z; Gao J; Tan W
    Cancer Lett; 2017 Oct; 406():27-35. PubMed ID: 28797844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma.
    Alessandrini L; Franz L; Ottaviano G; Ghi MG; Lanza C; Blandamura S; Marioni G
    Oral Oncol; 2020 Sep; 108():104836. PubMed ID: 32512470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.